- Conditions
- Palmar-Plantar Erythrodysesthesia, Breast Cancer
- Interventions
- Cream, 0.1% Uracil Cream
- Drug
- Lead sponsor
- Nanometics (d.b.a. PHD Biosciences)
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 18 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2011
- U.S. locations
- 6
- States / cities
- Birmingham, Alabama • Palm Springs, California • Evansville, Indiana + 3 more
Source: ClinicalTrials.gov public record
Updated Oct 7, 2019 · Synced May 21, 2026, 10:12 PM EDT